EUVIMEDEUVIMED entdecken
Crossref

Discovery of a Targeted Prodrug System Activated by Reactive Oxygen Species to Enhance Diagnostic and Therapeutic Efficacy of Photodynamic Therapy

Jin Wang, Yanchen Li, Junyu Zhang, Tingting Liu, Roujia Lin, Yuanyuan Shan, Jie Zhang iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.5c01296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Jin Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China. Hauptthemen laut MEDLINE: Photochemotherapy, Reactive Oxygen Species, Prodrugs, Photosensitizing Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Natural Science Basic Research Program of Shaanxi Province, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photodynamic therapy (PDT) alone is not as effective as expected due to its poor targeting and influence by the tumor microenvironment. In this study, combined with the strategy of controlled release and fluorescence illumination, we developed a cancer-targeted and activated photodynamic functional molecule, RQP. This study successfully demonstrated the mechanism of action of RQP, which could effectively differentiate between normal and tumor cells for precise distribution and activation of tumors, specifically release methylene blue (MB) as an effective photosensitizer and ROS detector for targeted phototherapy, and trigger immune activation, thereby synergistically exerting an effective antitumor effect. Meanwhile, in vivo near-infrared fluorescence imaging could efficiently visualize tumor tissues and monitor therapeutic efficacy in real time, providing a comprehensive and efficient therapeutic integration strategy for tumor treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyReactive Oxygen SpeciesProdrugsPhotosensitizing AgentsAntineoplastic AgentsHumansAnimalsMethylene BlueMiceCell Line, TumorOptical ImagingNeoplasmsMice, Inbred BALB C

Substanzen

Reactive Oxygen SpeciesProdrugsPhotosensitizing AgentsMethylene BlueAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
  • School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, China.

ORCID-Profile: Jie Zhang

Förderung

  • Natural Science Basic Research Program of Shaanxi Province
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Key Research and Development Projects of Shaanxi Province

Zitieren

APA

Wang, J., Li, Y., Zhang, J., Liu, T., Lin, R., Shan, Y., & Zhang, J. (2025). Discovery of a Targeted Prodrug System Activated by Reactive Oxygen Species to Enhance Diagnostic and Therapeutic Efficacy of Photodynamic Therapy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c01296

Vancouver

Wang J, Li Y, Zhang J, Liu T, Lin R, Shan Y, et al. Discovery of a Targeted Prodrug System Activated by Reactive Oxygen Species to Enhance Diagnostic and Therapeutic Efficacy of Photodynamic Therapy. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c01296

BibTeX
@article{Wang2025,
  author = {Wang, Jin and Li, Yanchen and Zhang, Junyu and Liu, Tingting and Lin, Roujia and Shan, Yuanyuan and Zhang, Jie},
  title = {Discovery of a Targeted Prodrug System Activated by Reactive Oxygen Species to Enhance Diagnostic and Therapeutic Efficacy of Photodynamic Therapy},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.5c01296}
}
Kostenlos starten →